Lunit Publicly Opens "Lunit INSIGHT,"
a Web-based AI Analytics Platform at RSNA 2017
- First live-demonstration showcase to be held at RSNA 2017, North Hall, #8164
- Top-notch AI technology with 97% standalone accuracy in lung cancer detection, 99% for consolidation and pneumothorax.
- Clinically validated to improve diagnostic performance of its users up to 20%.
- Available free to the public; upload medical images and get results in a few seconds
You are cordially invited to visit us at our RSNA booth (North Hall, #8164).
Demos for Lunit’s AI solutions, including chest x-ray, mammography, chest CT, and digital breast tomosynthesis are available with many interesting cases.
Lunit, founded in 2013, is one of the top international medical AI companies, named in CB Insights “AI 100” startups list as one of the leaders transforming healthcare industry. Lunit has proven high-end technology, recognized at international competitions such as ImageNet (5th place, 2015), TUPAC 2016 (1st place), and Camelyon 2017 (1st place), surpassing top companies like Google, IBM, and Microsoft.